About the Author
Subscribe to the latest updates in life science
Expert perspectives delivered to your inbox — pick your interests.
No spam, ever. Unsubscribe anytime.
ATMPs in a nutshell: what you should know about classification, quality and go to market
Advanced therapy medicinal products (ATMPs) is the group of therapies in which we use cells, genes, engineered tissues and combinations of the above.
Keep reading
Related articles
Feb 13, 2026
Deciding Early on an Orphan Strategy: A Strategic Choice, Not a Checkbox
Orphan strategy decisions go beyond incentives. Learn how regulatory definitions, evidence requirements, timing, and exclusivity across the EU, US, and UK shape early biotech development strategy.
Read more
Feb 9, 2026
Nitrosamine Impurities in Medicinal Products: Risks and Regulatory Insights
Learn about nitrosamine impurities in medicinal products, their causes, regulatory guidance, and strategies for risk evaluation and mitigation.
Read more
Oct 27, 2025
Environmental Risk Assessments (ERA) in Pharma: Balancing Health & Environment
Explore how Environmental Risk Assessment (ERA) helps ensure medicines heal us without harming the planet, balancing healthcare advances with ecological preservation.
Read more